Healthcare provider profile · identity verified

Catherine J Edmonds, MD

Family Practice · MILLERSVILLE, PA · NPI 1356398580

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	470	134
Levothyroxine Sodium	Levothyroxine Sodium	342	92
Rosuvastatin Calcium	Rosuvastatin Calcium	282	82
Metoprolol Succinate	Metoprolol Succinate	264	72
Lisinopril	Lisinopril	248	73
Omeprazole	Omeprazole	228	67
Amlodipine Besylate	Amlodipine Besylate	214	59
Losartan Potassium	Losartan Potassium	203	53
Sertraline Hcl	Sertraline Hcl	191	51
Simvastatin	Simvastatin	162	53
Gabapentin	Gabapentin	151	46
Eliquis	Apixaban	130	24
Hydrochlorothiazide	Hydrochlorothiazide	125	35
Alprazolam	Alprazolam	108	35
Albuterol Sulfate Hfa	Albuterol Sulfate	107	40
Pantoprazole Sodium	Pantoprazole Sodium	98	33
Famotidine	Famotidine	97	39
Furosemide	Furosemide	87	27
Metformin Hcl	Metformin Hcl	87	26
Citalopram Hbr	Citalopram Hydrobromide	82	28
Escitalopram Oxalate	Escitalopram Oxalate	77	26
Warfarin Sodium	Warfarin Sodium	68	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	20
Metoprolol Tartrate	Metoprolol Tartrate	63	16
Metformin Hcl Er	Metformin Hcl	62	21
Tramadol Hcl	Tramadol Hcl	59	13
Synthroid	Levothyroxine Sodium	51	14
Duloxetine Hcl	Duloxetine Hcl	48	16
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Potassium Chloride	Potassium Chloride	47	12
Triamcinolone Acetonide	Triamcinolone Acetonide	46	32
Montelukast Sodium	Montelukast Sodium	45	15
Fluoxetine Hcl	Fluoxetine Hcl	44	11
Glipizide Er	Glipizide	44	14
Ezetimibe	Ezetimibe	43	14
Atenolol	Atenolol	40	12
Trazodone Hcl	Trazodone Hcl	40	14
Bupropion Xl	Bupropion Hcl	39	12
Meloxicam	Meloxicam	39	16
Estradiol	Estradiol	37	20
Januvia	Sitagliptin Phosphate	37	suppressed
Jardiance	Empagliflozin	37	suppressed
Spironolactone	Spironolactone	37	13
Zolpidem Tartrate	Zolpidem Tartrate	37	11
Diclofenac Sodium	Diclofenac Sodium	36	suppressed
Carvedilol	Carvedilol	34	suppressed
Memantine Hcl	Memantine Hcl	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	13
Ozempic	Semaglutide	33	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	31	31
Lorazepam	Lorazepam	31	11
Buspirone Hcl	Buspirone Hcl	30	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	30	13
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Myrbetriq	Mirabegron	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Allopurinol	Allopurinol	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Cephalexin	Cephalexin	25	20
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Nystatin	Nystatin	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Finasteride	Finasteride	22	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	22	16
Amoxicillin	Amoxicillin	21	15
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	18	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Lovastatin	Lovastatin	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Bumetanide	Bumetanide	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Trimethoprim	Trimethoprim	15	suppressed
Econazole Nitrate	Econazole Nitrate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Verapamil Er Pm	Verapamil Hcl	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Concerta	Methylphenidate Hcl	11	suppressed
Klayesta	Nystatin	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error